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Abstract 
Essential oil of cinnamon (Cinnamomum zeylanicum) has been used in medicine and food 
additives. In the present work, we examined the antifungal activity of essential oil extracted from 
C. zeylanicum bark against oral opportunistic strains of Candida albicans. In addition, we 
verified the capability of this essential oil to inhibit fungal adhesion to buccal epithelial cells 
(BECs), germ tube formation, and proteinase activities. Cinnamon oil presented minimum 
inhibitory concentration (MIC) values that ranged from 31.2 to 125 µg mL
-1 
against the isolates 
of the tested C. albicans strains. Cinnamon essential oil could inhibit the adhesion of C. albicans 
to BECs for all of the isolates tested in present study. The C. albicans strains showed inhibited 
proteinase production after treatment with cinnamon oil, based on the MIC values determined 
for each C. albicans strain. Cinnamon oil was also able to inhibit the germ tube formation of all 
isolates of C. albicans, with the percentage of inhibition ranging from 44.7 to 82.9%. Our results 
showed that cinnamon oil presented potent antifungal activity and the ability to inhibit virulence 
factors of oral pathogenic strains of C. albicans. 
Keywords: Adhesion; Cinnamon oil; Germ tube; Proteinase. 
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INTRODUCTION 
Essential oils are volatile, natural, complex compounds 
with a strong scent that are produced as secondary 
metabolites by aromatic plants (Bakkali et al., 2008). The 
genus Cinnamomum comprises approximately 250 species 
that are widely distributed in China, India, and Australia 
(Jayaprakasha et al., 2003). Cinnamomum zeylanicum 
(cinnamon) bark is used worldwide as a spice. Cinnamon is 
employed in cooking as a condiment and flavoring material 
and is largely used in the preparation of certain desserts, 
chocolate, spicy candies, tea, hot cocoa, and liqueurs 
(Shan et al., 2005; Sathishkumar et al., 2009). Cinnamon 
oil from C. zeylanicum bark commonly presents 
antimicrobial and antifungal properties that have drawn 
great attention from many researchers (Singh et al., 1995; 
Hili et al., 1997; Ouattara et al., 1997; Park et al., 2000; 
Chang et al., 2001; Kim et al., 2004). 
Increased fungal resistance to classical drugs, drug 
toxicity, and the costs involved justify the search for new 
approaches to developing antifungal drugs. Among those 
new approaches, essential oils are one of the most 
promising groups of natural compounds for the prevention 
and treatment of fungal infection (Silva et al., 2011). 
Essential oils derived from aromatic plants are well known 
in traditional medicine as antimicrobial agents and are 
characterized as food and feed preservatives, as inhibitors 
of mycotoxin production, and as antimycotic agents 
(Azzouz and Bullerman, 1982; Knobloch et al., 1989; 
Guimarães et al., 2010).  
Oropharyngeal candidiasis (OPC) is the most common 
opportunistic infection in immunocompromised patients. 
Although Candida albicans is a well-known etiological 
agent of OPC, in addition to being responsible for most 
yeast infections in humans, several other emerging 
Candida species, such as C. dubliniensis, C. glabrata, C. 
krusei, C. parapsilosis, and C. tropicalis, have also been 
associated with this disease (Horn et al., 2009). 
Considering increasing pathogen resistance and the 
toxicity of classical antifungal drugs, investigations of the 
antimicrobial activities, modes of action, and potential uses 
of essential oils and their components have garnered new 
attention in the search for new antimicrobial compounds 
(Silva et al., 2011). The development of new drugs with 
improved efficacy and safety or alternative modes of 
fighting infections are needed. Recent developments in 
fungal genomics have provided unprecedented 
opportunities to identify new antifungal drug targets and 
accomplish subsequent disease control. Targeting 
virulence and pathogenicity factors should provide 
alternatives to conventional drug targets and provide new 
options for the development of potential antifungal 
therapeutics for the treatment and/or prevention of localized 
or systemic fungal disease (Gauwerky et al., 2009). 
According Alksne and Projan (2001), the idea is no longer 
to try to kill the microorganism acting as a pathogen by any 
means, but rather to hinder the organism from causing any 
harm to the host. 
In this work, we examined the effects of essential oil 
extracted from C. zeylanicum against 28 strains of C. 
albicans isolated from OPC. We also verified the ability of 
this essential oil to inhibit the germ tube formation, 
adhesion to buccal epithelial cells (BECs), and proteinase 
activity of the tested C. albicans isolates. 
                                                        
MATERIALS AND METHODS 
Broth microdilution testing was performed in 
accordance with CLSI document M27-A3 (2008). 
Susceptibility was determined by the microbroth dilution 
method, which was performed in sterile flat-bottom 96-well 
microplates (Difco Laboratories, Detroit, MI, USA). The 
cinnamon oil was diluted in synthetic RPMI medium 
(Sigma, St. Louis, MO, USA) supplemented with L-
glutamine and buffered to pH 7.0 with 0.165 M morpholine 
propanesulfonic acid (MOPS; Sigma). As growth and 
sterility controls, RPMI alone was used, without the addition 
of the oil and solvent. Fluconazole (Pfizer Pharmaceuticals, 
USA) was included at a concentration of 0.125 to 64 µg 
mL
-1 
as the positive antifungal control. After assembly of the 
plates, each yeast strain was inoculated, and the plates 
were incubated at 35°C for 48 h. The tests were performed 
in triplicate. The endpoints were determined visually by 
comparison with the endpoints of the drug-free growth-
control well. The value of the minimum inhibitory 
concentration (MIC) was defined as the lowest extract 
concentration at which the well was optically clear and was 
expressed in µg mL
-1
. 
The preparation of HBECs for the adherence assays 
was performed as described by Kimura and Pearsall 
(1978) and Ellepola and Samaranayake (1998a,b) and 
modified by Lyon and Resende (2006) and Johann et al. 
(2007) The concentrations of cinnamon oil and fluconazole 
used in the assays were the same as those obtained in the 
MIC test. In the assay, 0.5 mL of the BEC suspension and 
0.5 mL of yeast suspension were mixed gently in tubes and 
incubated on a rotary incubator at 37°C for 1 h. The 
yeast/BEC suspension was then harvested onto a 12 µm 
pore-size polycarbonate filter and washed twice with 50 mL 
of PBS to remove unattached yeast. Next, the filter was 
carefully removed with forceps and placed firmly on a glass 
slide, with the BECs against the glass surface. After 10 s, 
the filter was gently removed, leaving the BEC adherent to 
the glass slide. The preparations were air dried, fixed with 
heat, and stained with gentian violet. 
The MIC values of cinnamon oil and fluconazole 
obtained for each strain were used to verify inhibition of the 
proteinase activity of these yeasts. A control consisting of 
SDB without any drugs was always included. A yeast 
suspension at an optical density of 1.5 at 520 nm was 
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prepared in PBS, and 1 mL of this suspension was added 
to 4 mL of SDB with cinnamon oil or fluconazole and to the 
control. This procedure yielded a suspension that 
presented between 10
6
 and 10
7
 cells mL
-1
. The tubes were 
incubated at 37°C for 60 min. After this brief exposure, the 
cinnamon oil or fluconazole was removed by two cycles of 
centrifugation with PBS for 10 min at 3000 g. The pellet 
was suspended in 3 mL of PBS. This procedure drastically 
reduces the concentration of cinnamon oil and fluconazole, 
minimizing any residual effect. Prior to the assays, viable 
counts of the control and test samples were performed 
after drug removal by inoculating an aliquot of the 
suspensions in SDA.  Proteinase activity was assayed on a 
solid medium containing bovine serum albumin (BSA), as 
described by Cassone et al. (1987). Each isolate was 
tested in triplicate. 
Percentage of inhibition of germ tube formation (GTF) 
by pathogenic isolates was performed according to the 
method described by Brayman and Wilks (2003). The 
absorbance at 590 nm was determined by using a 
VERSAmax (Molecular Devices) and the program 
SoftMax® Pro 5 (Molecular Devices, USA) for SpectraMax 
Plus. 
  
 
RESULTS AND DISCUSSION  
The results showed that essential oil from cinnamon 
(C. zeylanicum) inhibited the isolates of oral pathogenic 
Candida species. The MIC results for cinnamon oil are 
shown in Table 1. Cinnamon oil presented MIC values 
ranging from 31.2 to 125 µg mL
-1
 against the yeast strains 
tested. Two isolates of C. albicans showed more sensitivity 
to cinnamon oil at an MIC value of 31.2 µg mL
-1
. All tested 
yeast isolates were sensitive to fluconazole at an MIC 
value ≤16 µg mL
-1
. Other authors also showed that 
cinnamon oil has antifungal activity. Singh et al. (1995) 
described fungitoxic properties of the vapors of bark oil 
from C. zeylanicum against fungi involved in respiratory 
tract mycoses, such as Aspergillus niger, A. fumigatus, A. 
nidulans, A. flavus, C. albicans, C. tropicalis, and 
Histoplasma capsulatum. According Singh et al. (1995), 
cinnamic aldehyde is an active fungitoxic constituent of C. 
zeylanicum bark oil. Unlu et al. (2010) analyzed cinnamon 
oil by gas chromatography-mass spectrometry and 
observed the presence of nine constituents, with (E)-
cinnamaldehyde, benzaldehyde, and (E)-cinnamyl acetate 
as major compounds. Unlu et al. (2010) also tested 
essential oil from the bark of C. zeylanicum and found 
inhibitory activity against the tested species of Candida, 
with MIC values ranging from 40-1000 µg mL
-1
, which are 
values similar to those found in the present work (32.5-125 
µg mL
-1
). Our results showed that essential oil from 
cinnamon has antifungal activity. Fluconazole is a 
therapeutic option for various types of fungal diseases, 
including oral candidiasis. In particular, this drug is relevant 
to localized candidiasis in HIV-infected patients. In this 
group of patients, however, the development of fluconazole 
resistance has become a problem, leading to treatment 
failure (Enwuru et al., 2008; Gauwerky et al., 2009). The 
use of essential oil from cinnamon could be recourse in the 
treatment of patients with oral candidiasis. Given that 
cinnamon is already used as a food additive and has high 
human consumption worldwide
 
(Wang et al., 2009), this 
spice could present low or not present toxicity to people 
using these food products. 
 
 
Table 1. Minimal inhibitory concentrations (MICs) of essential oil from Cinnamomum zeylanicum (cinnamon) and 
fluconazole against 28 oral Candida albicans strains (values in μg mL
-1
).  
 
MIC (μg mL
-1
) 
Yeast (number of isolates) Cinnamon oil Fluconazole 
C. albicans (2) 31.2 16.0-8.0 
C. albicans (16) 62.5 16.0-0.12 
C. albicans (10) 125.0 4-0.06 
 
 
Pathogenic Candida species produce several virulence 
factors that are essential for causing disease in a host. 
These factors include host recognition biomolecules 
(adhesins), morphogenesis-inducing factors (the reversible 
transition between unicellular yeast cells and filamentous 
growth forms), and aspartyl proteases and phospholipases. 
These virulence factors can be important targets in the 
development of new antifungal drugs (Calderone and 
Fonzi, 2001). In the present work, Cinnamon oil was also 
tested for its ability to inhibit the adhesion of C. albicans to 
BECs (Table 2 and figure 1A,B). Cinnamon oil inhibited the 
adhesion of all isolates of C. albicans to BECs. The 
percentage of inhibition ranged from 100 to 19.3%, and 14 
of 29 isolates presented inhibition of the adhesion to BECs 
between 100 and 80%. Cinnamon oil presented a better 
capacity to inhibit the adhesion of isolates of C. albicans to 
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BECs than did fluconazole. Fluconazole showed a 
percentage of inhibition that ranged from 96.5 to 0%, and 
most (21 isolates) of the yeast strains were inhibited at a 
percentage less than 57%. For only one isolate of C. 
albicans, fluconazole presented better adhesion inhibition 
than did cinnamon oil. Four isolates of C. albicans did not 
present inhibited adhesion when treated with fluconazole. 
However, cinnamon oil reached an inhibition of the 
adhesion ability of the same isolates of 88.5, 38.7, 19.2, 
and 79.5%. In addition, cinnamon oil also inhibited the 
adhesion of C. albicans to BECs better than fluconazole 
have done for 27 of the isolates tested. Ellepola and 
Samaranayake (1998b) also observed a very low degree of 
C. albicans adhesion inhibition by fluconazole. Several 
plant extracts and antifungal drugs have already been 
tested with the objective of inhibiting the adhesion of C. 
albicans to BECs (Ellepola and Samaranayake (1998a; 
Johann et al., 2007; Johann et al., 2008), but the present 
study is the first to examine the ability of the essential oil 
from the bark of C. zeylanicum to inhibit adhesion to BECs. 
Our results showed that essential oil from the bark of C. 
zeylanicum can inhibit the adhesion of C. albicans to BECs, 
therefore decreasing the virulence of oral pathogenic 
strains of C. albicans. 
 
 
 
Table 2. Percentage of inhibition of the adhesion of C. albicans to BECs of each C. albicans strain.  
 
 
 
Inhibition of the adhesion of C. albicans to BECs 
 C. albicans strains Fluconazole Cinnamon oil 
UFMG 12.2B 43.33 90 
UFMG 34.1A 49.12 84.21 
UFMG 4.1D 0.00 88.52 
UFMG 30.2A 53.77 97.17 
UFMG 4.2A 21.62 91.89 
UFMG 7.1A 35.05 91.75 
UFMG 11.2B 56.74 97.19 
UFMG 29.1D 4.35 91.30 
UFMG 23.2D 27.03 78.38 
UFMG 21.1D 18.33 75.00 
UFMG 31.1B 26.00 100.00 
UFMG 1A 0.00 38.71 
UFMG 5.2A 0.00 19.23 
UFMG 13.1E 40.98 86.89 
UFMG 3.1A 65.95 79.46 
UFMG 2.1A 16.30 81.52 
UFMG 9.1B 33.08 92.48 
UFMG 9.2A 0.00 79.59 
UFMG 33.1A 51.02 93.88 
UFMG 6 51.16 56.98 
UFMG 1E 29.41 41.18 
UFMG 15.3C 96.55 90.80 
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Fig. 1. Adhesion of Candida albicans to human buccal 
epithelial cells (HBEC). A) Percentage average of 
inhibition of the adhesion of C. albicans to HBECs. B) 
Optical microscopy (40x) photos of C. albicans 
adhered buccal epithelial cells (gentian violet stain). 
 
 
The tested C. albicans strains demonstrated alteration 
in their proteinase production after treatment with cinnamon 
oil at the MIC values determined for each yeast strain. 
Table 3 shows that cinnamon oil possesses very similar 
activity to fluconazole in the alteration of proteinase 
secretion. Except for one isolate of C. albicans, cinnamon 
oil showed better activity than did fluconazole in the 
inhibition of proteinase production. One isolate did not 
present proteinase production inhibition by fluconazole, 
whereas cinnamon oil inhibited the activity of the proteinase 
of the same isolate by 66%. Cinnamon oil inhibited 
proteinase production by the C. albicans strains tested in 
the present work. The secretion of proteinase is a major 
virulence factor of C. albicans and is responsible for 
causing tissue damage, providing nutrition to the yeast 
cells, and evading immune responses (Hube and Naglik, 
2001; Gauwerky et al., 2009). Shreaz et al. (2012) showed 
that three compounds (cinnamaldehyde, 4-hydroxy-3-
methoxy cinnamaldehyd, and 3,5-dimethoxy-4-hydroxy 
cinnamaldehyde) that occur naturally in the bark of the 
cinnamon tree and other species of the genus 
Cinnamomum, such as camphor and cassia, significantly 
inhibited phospholipase and proteinase secretion by oral C. 
albicans isolates. The significant decrease in proteinase 
and phospholipase secretion by cinnamaldehyde and its 
derivatives can be attributed to ATPase-dependent efflux 
mechanisms (Shreaz et al., 2012). These compounds may 
also have been responsible for the inhibition of the 
proteinase activity of the C. albicans strains observed in the 
present work.  
The cultivation of the isolates of C. albicans in 
polystyrene microplates resulted in germ tube attachment 
to the surface of each well. In the present work, 92.2% of 
untreated C. albicans cells presented germ tube formation 
under the conditions tested, whereas only two isolates of C. 
albicans did not (Table 4). Cinnamon oil was able to inhibit 
germ tube formation by the isolates of C. albicans. 
Considering all isolates tested, 16 presented inhibition of 
germ tube formation between 44.7 and 82.9% after 
treatment with cinnamon oil at concentration values ranging 
from 62.5-500 µg mL
-1
. One isolate of C. albicans 
presented 82.9% inhibition of germ tube formation, but at a 
concentration of 250 µg mL
-1
 cinnamon oil. The 
compounds cinnamaldehyde, 4-hydroxy-3-methoxy 
cinnamaldehyd, and 3,5-dimethoxy-4-hydroxy 
cinnamaldehyde, which are present in cinnamon oil, inhibits 
the transition of C. albicans cells from yeast to hyphae 
(Shreaz et al., 2012). Our results also showed that 
cinnamon oil inhibited the germ tube formation of the tested 
C. albicans strains, which is the initial stage of hyphal 
formation. The formation of germ tubes could be a new 
target for drugs that is more sensitive to drug intervention 
than the inhibition of growth is (Brayman and Wiks, 2003). 
According with Brayman and Wiks (2003) and Hector 
(1993), the formation of germ tubes is related to the 
activation of glucan synthase because there is extensive 
synthesis of cell walls during the formation of hyphae. 
Therefore, the inhibition of germ tube formation could be 
associated with inhibition of glucan synthase, which could 
also be an interesting target for new antifungal drugs. The 
inhibition of glucan synthase is related to the integrity of the 
fungal cell wall, and this target is not related to any other 
target in the mammalian host (Brayman and Wiks, 2003; 
Gauwerky et al., 2009). 
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Table 3. Percentage of inhibition of proteinase activity of Candida albicans by essential oil from Cinnamomum 
zeylanicum (cinnamon).  
*: not tested; UFMG: strains of C. albicans from the culture collection of the Universidade Federal de Minas Gerais, Belo 
Horizonte, MG, Brazil. 
 
 
 
In the present work, we characterized the antifungal 
activity of cinnamon oil and its potent inhibition of virulence 
factors of oral pathogenic C. albicans. Cinnamon oil 
showed a better ability to inhibit the adhesion of C. albicans 
to BECs than did fluconazole. In addition, cinnamon oil 
decreased proteinase secretion and inhibited the formation 
of germ tubes by C. albicans treated with this essential oil. 
This work suggests options for expanding the utility of the 
essential oil of the bark of C. zeylanicum as an antifungal 
agent against oral infection by C. albicans. 
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 Inhibition of proteinase activity 
 C. albicans strains Fluconazole Cinnamon oil 
UFMG 12.2B 50 50 
UFMG 34.1A 34 34 
UFMG 4.1D 0 0 
UFMG 30.2A 0 0 
UFMG 4.2A 0 0 
UFMG 7.1A 40 40 
UFMG 11.2B 34 34 
UFMG 29.1D 25 25 
UFMG 23.2D 34 34 
UFMG 21.1D 34 34 
UFMG 31.1B 0 0 
UFMG 1A 0 0 
UFMG 5.2A -* - 
UFMG 13.1E 50 50 
UFMG 3.1A - - 
UFMG 2.1A 0 0 
UFMG 9.1B - - 
UFMG 9.2A 0.00 66 
UFMG 33.1A 0 0 
UFMG 6 25 25 
UFMG 1E 30 40 
UFMG 15.3C - - 
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Table 4. Percentage of inhibition of germ tube formation (GTF) by pathogenic isolates of Candida albicans in the 
presence of essential oil from Cinnamomum zeylanicum (cinnamon) at different concentrations.  
 
ni: not inhibited under the tested conditions; -: not tested; N: no germ tube formation under the tested conditions; UFMG: 
strains of C. albicans from the culture collection of the Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. 
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